SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-104987
Filing Date
2021-08-13
Accepted
2021-08-13 14:53:47
Documents
1
Period of Report
2021-08-10
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2124980d1_8k.htm 8-K 19432
  Complete submission text file 0001104659-21-104987.txt   20544
Mailing Address 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103
Business Address 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103 267-765-3222
IBERE PHARMACEUTICALS (Filer) CIK: 0001835205 (see all company filings)

IRS No.: 981564986 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40119 | Film No.: 211171624
SIC: 6770 Blank Checks